ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2013

Sep 24, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARROWHEAD RESEARCH CORP (ARWR)
CIK: 0000879407
Period of Report: 2013-09-21

Reporting Person: Anzalone Christopher Richard (Director, President and CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-09-21	Stock Option	$4.75	A	69991	Acquired	2023-09-21	Common Stock (69991)	Direct

Footnotes

F1: Option vests in 48 equal monthly installments beginning 10/01/13.